Hisamitsu Pharmaceutical Co (TSE:4530) Interest Expense : 円-18 Mil (TTM As of Nov. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Hisamitsu Pharmaceutical Co's interest expense for the three months ended in Nov. 2023 was 円 -5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Nov. 2023 was 円-18 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Hisamitsu Pharmaceutical Co's Operating Income for the three months ended in Nov. 2023 was 円 3,874 Mil. Hisamitsu Pharmaceutical Co's Interest Expense for the three months ended in Nov. 2023 was 円 -5 Mil. Hisamitsu Pharmaceutical Co's Interest Coverage for the quarter that ended in Nov. 2023 was 774.80. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hisamitsu Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Interest Expense Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Interest Expense

Get a 7-Day Free Trial

-19.00

-10.00

-20.00

-15.00

-18.00

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Interest Expense	Get a 7-Day Free Trial															-3.00	-	-7.00	-5.00	-6.00

Hisamitsu Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-18 Mil.

Hisamitsu Pharmaceutical Co (TSE:4530) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hisamitsu Pharmaceutical Co's Interest Expense for the three months ended in Nov. 2023 was 円-5 Mil. Its Operating Income for the three months ended in Nov. 2023 was 円3,874 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Nov. 2023 was 円95 Mil.

Hisamitsu Pharmaceutical Co's Interest Coverage for the quarter that ended in Nov. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Nov. 2023 )	/	Interest Expense (Q: Nov. 2023 )
	=	-1	*	3874	/	-5
	=	774.80

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Hisamitsu Pharmaceutical Co Inc has enough cash to cover all of its debt. Its financial situation is stable.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines